Wikidata

(Q61980965)

English

Efficacy and Safety of Pazopanib Monotherapy After First Line Chemotherapy in Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

clinical trial

In more languages

Statements

title
A Phase III Study to Evaluate the Efficacy and Safety of Pazopanib Monotherapy Versus Placebo in Women Who Have Not Progressed After First Line Chemotherapy for Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (English)
0 references
sponsor
Novartis
0 references
country
Australia
0 references
Austria
0 references
Belgium
0 references
Denmark
0 references
France
0 references
Germany
0 references
Republic of Ireland
0 references
Italy
0 references
Japan
0 references
Norway
0 references
Spain
0 references
Sweden
0 references
Taiwan
0 references
start time
26 May 2009
0 references
end time
8 July 2012
0 references
number of participants
940
0 references
research site
Novartis
0 references
minimum age
18 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q61980965&oldid=2149197138"